APA (7th ed.) Citation

Kataoka, H., Hamano, S., Aoyama, M., Mori, Y., Tanaka, M., Hayashi, N., . . . Joh, T. (2014). 760: Enhanced antitumor effects of oncolytic reovirus and trastuzumab combination therapy in human HER2-positive gastric cancer. European Journal of Cancer, 50, S183. https://doi.org/10.1016/S0959-8049(14)50667-3

Chicago Style (17th ed.) Citation

Kataoka, H., S. Hamano, M. Aoyama, Y. Mori, M. Tanaka, N. Hayashi, E. Kubota, R. Johnston, and T. Joh. "760: Enhanced Antitumor Effects of Oncolytic Reovirus and Trastuzumab Combination Therapy in Human HER2-positive Gastric Cancer." European Journal of Cancer 50 (2014): S183. https://doi.org/10.1016/S0959-8049(14)50667-3.

MLA (9th ed.) Citation

Kataoka, H., et al. "760: Enhanced Antitumor Effects of Oncolytic Reovirus and Trastuzumab Combination Therapy in Human HER2-positive Gastric Cancer." European Journal of Cancer, vol. 50, 2014, p. S183, https://doi.org/10.1016/S0959-8049(14)50667-3.